Bayesian model reveals latent atrophy factors with dissociable cognitive trajectories in Alzheimer’s disease
Open Access
- 4 October 2016
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (42) , E6535-E6544
Abstract
Significance: Alzheimer’s disease (AD) affects 10% of the elderly population. The disease remains poorly understood with no cure. The main symptom is memory loss, but other symptoms might include impaired executive function (ability to plan and accomplish goals; e.g., grocery shopping). The severity of behavioral symptoms and brain atrophy (gray matter loss) can vary widely across patients. This variability complicates diagnosis, treatment, and prevention. A mathematical model reveals distinct brain atrophy patterns, explaining variation in gray matter loss among AD dementia patients. The atrophy patterns can also explain variation in memory and executive function decline among dementia patients and at-risk nondemented participants. This model can potentially be applied to understand brain disorders with varying symptoms, including autism and schizophrenia.Keywords
All Related Versions
Funding Information
- National University of Singapore (Tier 1; Strategic Research (DPRT/944/09/14); SOM Aspiration Fund (R185000271720); YIA)
- Ministry of Education - Singapore (MOE2014-T2-2-016)
- MOH | National Medical Research Council (CBRG14nov007; NMRC/CG/013/2013)
- Massachusetts General Hospital (P41EB015896; 1S10RR023401; 1S10RR019307; 1S10RR023043)
This publication has 48 references indexed in Scilit:
- FreeSurferNeuroImage, 2012
- The organization of the human cerebral cortex estimated by intrinsic functional connectivityJournal of Neurophysiology, 2011
- Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective studyThe Lancet Neurology, 2011
- Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristicsJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- The neuropathology of probable Alzheimer disease and mild cognitive impairmentAnnals of Neurology, 2009
- Neuropsychological Assessment of DementiaAnnual Review of Psychology, 2009
- Multi-site voxel-based morphometry: Methods and a feasibility demonstration with childhood absence epilepsyNeuroImage, 2008
- Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's diseaseJournal of the International Neuropsychological Society, 2008
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991